Strategic partnerships Medical Murray has recently formed a strategic partnership with Merge Med to accelerate early medical device innovation and regulated development, presenting an opportunity to offer co-development or integration services, joint ventures, or bundled development programs.

Expansion footprint With multiple facilities across the United States and recent North Carolina expansion history, there is potential to offer regional manufacturing scale, capacity expansion consulting, and logistics optimization for catheter systems and implant production.

Acquisition activity Recent asset sale to Aptyx Interventional Systems indicates a dynamic ownership and asset realignment; potential conversations around transitional manufacturing partnerships, legacy product support, or spillover opportunities for contract manufacturing of complex catheter components.

Regulatory-ready capacity ISO 13485 certified cleanrooms and full turnkey development indicate readiness for regulated production; sales opportunities exist for complete design-to-manufacture outsourcing, quality systems alignment, and documentation-heavy programs for minimally invasive devices.

Technological capabilities In-house molding, micro-scale part features, and advanced catheter tip technologies enable cross-sell of materials, tooling, and process development services, including insert molding, biocompatible polymers, and complex geometry attachments for urology and vascular devices.